"We see AI right now as an accelerant," says Unity SVP Adam Smith. "Players are going to accept this method of development." ...

For years, AI in drug discovery has been held back by a deceptively simple problem: the data isn’t good enough. Mountains of sequencing, pooled perturbation studies, and those mixed-cell experiments ...

A breakthrough live-cell sensor makes DNA repair visible as it happens, unlocking new possibilities in biology and medicine.

In today’s interview, we speak to Matthew Loose about how real-time sequencing could transform cancer diagnostics and care.